Open-Label Extension Study of PRX012 in Subjects with Alzheimer’s Disease Who Were Enrolled in Study PRX012-101 or PRX012-102

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2023-503729-20-00

Acronym

PRX012-103

Enrollment

Registered

2024-01-29

Start date

2024-03-27

Completion date

2025-08-27

Last updated

2025-07-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alzheimer’s Disease

None listed

Sex/Gender

All

Age

18 Years to No maximum

Poland, Spain

None listed

Source: EU CTIS · Data processed: Feb 4, 2026